跳至主要内容
临床试验/KCT0000933
KCT0000933尚未招募未知

Thrombolytic efficacy of intravenous recombinant tissue plasminogen activator with different doses

Yonsei University Health System, Severance Hospital0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • ? Above 20 year old
  • ? Clear onset time, acute middle cerebral artery infarction patients within 3 hours after onset
  • ? Above 4 of National Institute of Health Stroke Scale
  • ? thin-section noncontrast CT before and after intravenous recombinant tissue plasminogen activator
  • ? patients who treated with intravenous recombinant tissue plasminogen activator
  • ? agreement with this study

排除标准

  • ? contraindication of intravenous recombinant tissue plasminogen activator
  • I.Comatous mentality
  • II.rapidly improved neurologic deficit or below 4 of National Institute of Health Stroke Scale 4
  • III.Septic embolism
  • IV.Risk of bleeding: Known AV malformation of aneurysm, within 7 days of non-compressible site arterial puncture, SAH , INR> 1.7, within 48 hours of heparin and aPTT >1.5 times the upper limit of normal
  • V.otherwise relative contraindications
  • ? contraindication of CT
  • ? impossible case of thin section brain CT before and after treatment

研究者

相似试验